Skip to main content Deutsch


Our division has a broad scientific interest in all inflammatory rheumatic diseases.

The research activities of recent years have led to an unexpectedly rapid development of new drugs as well as new therapeutic strategies. For example, the current and globally valid new criteria for rheumatoid arthritis were developed here at the Medical University of Vienna under the leadership of the Vienna Rheumatology Department.

In addition to direct clinical research on humans, which is coordinated by the clinical trials working group, basic rheumatological and immunological research is another pillar and source of innovation. This not only provides new insights into how molecules, messengers and cells interact in disease development and disease activity, but also forms the basis for the development of new drugs and therapeutic strategies for rheumatic diseases.

The Department of Rheumatology has a strong international network in all its scientific activities and its scientific success has also led to repeated recognition as a European Center of Excellence. Our claim is not only to research at the pulse of time, but also to orient ourselves as a driving force in the field of rheumatology to the questions and requirements of the future.

European Consortiums

The Division of Rheumatology is leading SQUEEZE, an ambitious Horizon Europe-funded Grant led by our division, which runs from 2022 to 2027. SQUEEZE is a consortium of 13 research centers, hospitals and SMEs from eight European countries who aim to improve the efficacy, safety and satisfaction with existing therapies for Rheumatoid Arthritis (RA) patients. SQUEEZE Website | SQUEEZE Introductory video

Our Division is also a key member of two additional Horizon Europe Consortia: STRATA-FIT (from 2023 to 2029) and DARK MATTER (from 2024 to 2029).

EULAR Centre of Excellence

The Clinical Department of Rheumatology has been an "EULAR Centre of Excellence" since 2005. This distinction is awarded for outstanding quality, especially in scientific work, to departments that make special contributions in the field of rheumatology.